Navigation Links
Natural tumor suppressor in body discovered by UCSD medical researchers

A natural tumor suppressor that could potentially be turned on in certain cancer cells to prevent the formation of tumors has been discovered by researchers at the University of California, San Diego (UCSD) School of Medicine.

Located on chromosome 18 and called PH domain Leucine-rich repeat Protein Phosphatase (PHLPP, pronounced "flip"), the tumor suppressor is described in the April 1, 2005 issue of the journal Molecular Cell. The scientists demonstrated that PHLPP deletes a phosphate molecule, causing termination of cell-growth signaling by a protein called Akt that controls the balance between cell growth leading to cancer and cell death that prevents tumor formation.

"A drug that turns on PHLPP, so that it suppresses cell growth caused by Akt, could be a potential cancer therapy," said the study's senior author, Alexandra C. Newton, Ph.D., UCSD professor of pharmacology. "Currently there are no compounds identified to directly stop Akt from causing cancer growth, once Akt signaling has been initiated."

Scientists have known that Akt is critical in regulating cell growth and death, and that it is linked to some of the most common human cancers. Although one group of scientists discovered a molecule called PTEN*, which prevents activation of Akt, no one to date had determined how to directly turn off Akt once it has been activated.

Since the Akt molecule is locked in the "on" position when it has phosphate on it, the UCSD team reasoned that there must be another molecule that will strip off the phosphate and lock Akt in the "off" position. The scientists conducted a database search of the human genome for a phosphatase, which is an enzyme that acts as a catalyst in regulating cellular processes by removing phosphate molecules. Based on the chemical components of Akt, they specifically looked for a phosphatase linked to the PH domain, a protein module found in a wide variety of chemical signaling proteins in organisms ranging from ye ast to humans.

Once they found PHLPP, which they discovered was expressed throughout the body, the scientists used biochemical and cellular studies in human and other mammalian tissue to determine that PHLPP levels are markedly reduced in several colon cancer and gliobastoma human cell lines that had elevated Akt phosphorylation. Reintroduction of PHLPP into the cell lines caused a dramatic suppression of tumor growth. With additional laboratory tests, the team found that PHLPP stops tumor growth by deleting a specific phosphate molecule at a position called Ser473 on Akt.

The scientists noted that PHLPP's role as a tumor suppressor would apply to all cancers where Akt is elevated, "which is a large number of cancers," Newton said.


'"/>

Source:University of California - San Diego


Related biology news :

1. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
2. Natural Killers Could Lead to New Hepatitis Treatments
3. Naturally occurring asbestos linked to lung cancer
4. Natural compound from pond scum shows potential activity against Alzheimers
5. Natural selection at single gene demonstrated
6. Natural vitamin E tocotrienol reaches blood at protective levels
7. Natural pine bark extract relieves muscle cramp and pain in athletes and diabetics
8. Natural protein stops deadly human brain cancer in mice
9. Natural anti-viral enzyme helps keep cancer cells alive, researchers find
10. Natural polyester makes new sutures stronger, safer
11. Natural gut hormone offers hope for new obesity drug
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/1/2018)... ... August 01, 2018 , ... Clinical Training for ... and Administrative staff. , This full day course is an interactive day with ... expose your staff to regenerative medicine procedures and processing techniques, and facility providing ...
(Date:7/31/2018)... ... July 31, 2018 , ... Lifecycle Biotechnologies, ... Business Development Manager. In this role, Mr. Muzek will lead the company-wide industrial ... growth and expansion. , With over 20 years in business development, Mr. ...
(Date:7/28/2018)... ... July 28, 2018 , ... Inthirani Arul, an evidence-based healer, today announces research ... inflammation and autoimmune disorders. , Biomarkers for immune function, blood, as well as, ... Over 110% increase in overall immunity as seen by the rise in antibody ...
Breaking Biology News(10 mins):
(Date:7/24/2018)... FORT WORTH, Texas (PRWEB) , ... July 24, 2018 , ... ... albumin (BSA) to support blood bank reagent suppliers. In Boval’s early days most ... lyophilization capabilities were added to produce BSA for diagnostic purposes after gel cards changed ...
(Date:7/22/2018)... ... July 19, 2018 , ... ... has joined their team. With more than ten years of strategic, result-oriented Channel ... his expertise as CallTower’s Channel Director for the Southwest and Mountain region. , ...
(Date:7/22/2018)... BETHESDA, Md. (PRWEB) , ... July 19, 2018 ... ... of the Freedom from Cancer Startup Challenge (FCSC), generously supported by the Laura ... is to advance 100+ breakthrough inventions -- conceived and developed at 55 institutions, ...
(Date:7/22/2018)... ... July 21, 2018 , ... Today the Weed Science Society of ... movement of dicamba herbicides is available on the Society’s website . The workshop ... stakeholders better understand and manage factors contributing to dicamba off-target movement. , ...
Breaking Biology Technology: